Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial

There is critical need for a clinically useful tool to predict antidepressant treatment outcome in major depressive disorder (MDD) to reduce suffering and mortality. This analysis sought to build upon previously reported antidepressant treatment efficacy prediction from 2-[(18)F]-fluorodeoxyglucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Kathryn R., Gardus, John D., Bartlett, Elizabeth A., Perlman, Greg, Parsey, Ramin V., DeLorenzo, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551925/
https://www.ncbi.nlm.nih.gov/pubmed/34689056
http://dx.doi.org/10.1016/j.nicl.2021.102858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551925/
https://www.ncbi.nlm.nih.gov/pubmed/34689056
http://dx.doi.org/10.1016/j.nicl.2021.102858

Ejemplares similares